If 2024 revenues are over $800,000 (report is due in the coming days), it would be a significant improvement over the $700k-ish reported in each of the last two years, which would propel the pps out of the trips. It would also generate some positive publicity in the financial media that would spur future product sales. With the huge USA market available to BIEL last year - after KT previously tried to weaponize their exclusive US rights (2022 and 2023) against us - increased revenue is likely.
(1)
(0)
BioElectronics Corporation (BIEL) Stock Research Links